AETHLON MEDICAL, INC. Deferred Offering Costs
AETHLON MEDICAL, INC. (AEMD) had Deferred Offering Costs of $394.19 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-08-13
- 2026-06-30: Deferred Offering Costs $394.19K.
- 2026-03-31: Deferred Offering Costs $210.99K.
- 2025-06-30: Deferred Offering Costs $9.10K.
- 2025-03-31: Deferred Offering Costs $0.00.
| Period end | Deferred Offering Costs |
|---|---|
| 2026-06-30 | $394.19K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $210.99K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $9.10K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $0.00 10-K · filed 2026-06-10 |
| 2024-12-31 | $54.75K 10-Q · filed 2025-02-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $277.83K 10-K · filed 2025-06-26 |
| 2023-03-31 | $0.00 10-K · filed 2024-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |